BioTrack Capital
Private equityGrand Cayman · Seed–Late Stage · 4 people tracked
Also known as BIOTRACK FUND II GP LIMITED
Investment thesis
BioTrack Capital is a venture capital firm founded in 2017 that invests in early-stage companies in biotechnology, medical devices, and healthcare-related sectors including artificial intelligence, digital health, and consumer health. The firm's investment team has backgrounds in research and development, clinical operations, consulting, and venture capital.
Source: firm website, verified Aug 11, 2026.
Team · 4 people
from public directories
Frequently asked questions
- What stage does BioTrack Capital invest at?
- BioTrack Capital invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does BioTrack Capital focus on?
- BioTrack Capital focuses on Biotech, Healthtech, Medical Devices.
- Where is BioTrack Capital located?
- BioTrack Capital is headquartered in Grand Cayman, CN.
Similar investors
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.